Christopher A. Lipinski

Christopher A. Lipinski is a medicinal chemist who is working at Pfizer, Inc. He is known for his "rule of five", an algorithm that predicts drug compounds that are likely to have oral activity. By the number of citations, he is the most cited author of some pharmacology journals: ''Journal of Pharmacological and Toxicological Methods'', ''Advanced Drug Delivery Reviews'', ''Drug Discovery Today: Technologies''. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Christopher A. Lipinski', query time: 0.02s Refine Results
  1. 1
    Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs

    Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs by Christopher A. Lipinski, Andrew G. Reaume

    Published 2022-08-01
    Get full text
    Article
  2. 2
    The rule of five should not impede anti-parasitic drug development

    The rule of five should not impede anti-parasitic drug development by James H. McKerrow, Christopher A. Lipinski, Ph.D., LLC

    Published 2017-08-01
    Get full text
    Article

Search Tools: